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ABSTRACT
Gilland, Kaitlyn Elizabeth. M.S., Purdue University, May 2016. Short-Term Effects
of a Western Diet on the Number of Brain-Derived Neurotrophic Factor
Immunoreactive Neurons in the Hypothalamic Arcuate, Ventromedial and
Paraventricular Nuclei. Major Professor: Edward Fox.
Brain-derived neurotrophic factor (BDNF) is an important anorexogenic factor and has
been shown to be involved in obesity. It is important to know when changes in BDNF
expression occur to possibly prevent development of dietary obesity. BDNF mRNA
decreases in response to long-term western diet (WD) exposure in the ventromedial
hypothalamus (VMH), yet no study has investigated the short-term effects of WD on
BDNF expression in the hypothalamus. It was hypothesized BDNF protein would
mirror a decrease in BDNF mRNA in the VMH when mice were fasted for 48-hours or
fed WD for 6-hours, 48-hours, 1-week and 3-week and decrease the number of BDNF
immunoreactive (IR) cells. Immunohistochemistry was used to stain for BDNF-IR
cells in the arcuate (ARC), VMH, paraventricular hypothalamus (PVN) and cortex.
Sections were imaged using confocal microscopy and cells were counted using Image J
software. Fasting resulted in decreases of BDNF-IR cell number in the ARC (32%) but
not in the VMH. No changes were seen at 6-hour, 48-hour and 3-weeks in any of the
brain areas between any of the diet manipulations. Near-significant increasing trends
were observed at 48 hours which become significant at 1-week in the VMH (29%) and

viii
CORTEX (17%). Longer fasts may be necessary to see significant decreases in the
VMH in fasted animals. An increase in BDNF-IR cell number at 1-week in the WD
group is likely to have occurred in attempt to inhibit overeating and food intake.

1

INTRODUCTION
Approximately 2.8 million individuals die globally as a result of obesity
(Ogden et al., 2012). Obesity directly impacts 35.7% of adults (2010) and 17% of
children (2010) in the United States. An estimated $147 billion dollars was spent in
the United States in 2008 on obesity related medical costs and the cost is thought to
have increased since then (Finkelstein et al, 2009). This dollar figure not only includes
medical costs from directly being obese but also the cost of secondary illnesses
attributed to obesity. Approximately 44% of all diabetes cases, 23% of ischemic heart
disease and somewhere between 7-41% of cancer cases are caused by obesity each year
(National Heart, Lung, and Blood Institute, 1998). Because of the vast number of
people directly impacted and the overwhelming economic effects, it is crucial to
determine the causes of overeating and develop treatments.
A study published in 2010 by the Metabolism Initiative and Program in
Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts assessed
249,796 individuals to reveal eighteen new loci related to obesity susceptibility. They
also confirmed fourteen previously known loci related to obesity. One of these
variants was BDNF (Speliotes et al., 2010). Variants in the receptor for BDNF,
tyrosine kinase B (TrkB), have also been linked to obesity (Yeo et al., 2004). Proper
binding of BDNF to TrkB causes autophosphorylation of the tyrosine residue in the
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TrkB receptor and then activates signaling pathways downstream (Yamada and
Nabeshima, 2003). These pathways include: diacylglycerol (DAG) eventually causing
cell adhesion and migration, inositol trisphosphate (IP3) to mobilize calcium stores,
phosphatidylinositide 3-kinases (PI3K) leading to synaptic plasticity and neurogenesis
and Ras (rat sarcoma; a small GTPase protein) signaling which can alter gene
expression. It has been demonstrated by blocking secondary signaling; animals
become obese (Yeo et al., 2004). This demonstrates BDNF and TrkB might contribute
to energy balance and have functions in feeding behavior. Variants in BDNF or TrkB
often begin to elucidate mechanisms of obesity and feeding behavior by observing how
small changes at the molecular level change behaviors.
Brain-Derived Neurotrophic Factor and the Brain
BDNF is a neurotrophic factor found in the central nervous system (Conner et
al., 1997) and thus is involved in many processes such as learning, memory and
neuronal homeostasis (Yamada & Nabeshima, 2003). It has been demonstrated BDNF
plays a role in synaptic function and neuronal development (Hofer & Barde, 1988).
Mice born with a global BDNF deletion die soon after birth as a result of
developmental defects (Ernfors, 1995). Another biological process BDNF is involved
in is feeding behavior.
More research is necessary to determine mechanistically how BDNF functions
in response to feeding. BDNF was first linked to obesity and feeding when BDNF was
administered through intracerebroventricular (ICV) injections into the brain of rats.
BDNF administration decreased body weight and food intake in these animals
(Pelleymounter et al., 1995; Lapchak and Hefti, 1992). Other studies investigated the
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effects of increasing BDNF levels within the brain and observed the resulting changes
in body weight and food intake. Infusions of exogenous BDNF injected in the dorsal
vagal complex (DVC), as well as the VMH and the PVN, showed decreased food
intake and decreased body weight (Bariohay et al., 2005; Unger et al., 2007; Wang et
al., 2007a & b). When BDNF expression was decreased in rodents, either by global
BDNF depletion (Kernie et al., 2000; Lyons et al., 1999; Fox & Byerly, 2004), BDNF
smooth muscle knockouts (Fox et al., 2013), conditional BDNF knockouts (Rios et al.,
2001) or BDNF knockdowns in VMH (Unger et al., 2007) have shown increased food
intake and increased body weight. These results demonstrate BDNF is essential for
normal feeding.
In the brain, BDNF is expressed in many areas including the DVC,
hippocampus, cortex and hypothalamus. Several regions within the hypothalamus
have been identified as key parts involved in feeding and satiety. These areas include
the VMH, the dorsal medial nucleus of the hypothalamus (DMH), the PVN, and the
ARC. The ARC projects to the PVN and receives inputs from the VMH (Toth &
Palkovits, 1998; Sternson et al., 2005). The ARC has TrkB receptors, but BDNF
mRNA is not produced in the ARC (Xu et al., 2003; Conner et al., 1997). There is
evidence that BDNF protein is present in the ARC (Conner et al., 1997).
BDNF protein expression is very high in neurons with their cell bodies in the
VMH. Reduction in BDNF protein expression in the VMH (and DMH) leads to
overeating and obesity in mice. Mice with a VMH BDNF deletion increased their food
intake by approximately 27% and were 41% heavier than control mice (Unger et al.,
2007). The VMH and PVN have both been identified as part of feeding and satiety
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circuits in many separate studies (Brooks & Lambert, 1946; Unger et al., 2007; Wang
et al., 2007b).
Levels of BDNF increase in the VMH in response to glucose, as early as thirty
minutes and stay elevated up to 120 minutes after administered by intraperitoneal
injection. These mRNA levels return to normal after 360 minutes post injection. This
finding supports the hypothesis of VMH BDNF as an important component to satiety
(Unger et al., 2007) and contributor to short-term food intake regulation. This also
suggests that BDNF protein responds quickly to nutritional state and could increase
after the consumption of food. Since BDNF responds quickly to nutritional state it is
important to investigate when BDNF protein amounts change and how much they
change by.
BDNF is also expressed in DMH neurons, but at much lower levels than in the
VMH neurons (Xu et al., 2003). Moreover, BDNF mRNA expression in the DMH
does not change in response to intraperitoneal administration of glucose or other
energy status signals (Xu et al., 2003, Tran et al., 2006; Unger et al., 2007). Therefore,
the DMH was not investigated in this study.
The paraventricular nucleus of the hypothalamus is another area of interest. It
receives inputs from the nucleus of the solitary tract (NTS), another area of the brain
involved in feeding. Outputs of the PVN include the lateral hypothalamus, NTS and
the intermediolateral (IML) column of the spinal cord (Saper et al., 1976; Sawchenko
and Swanson, 1982; Willett et al., 1987; Blair et al., 1996). Several experiments have
been performed modifying the BDNF levels in the PVN. Injections of BDNF into the
PVN of normal animals dose- dependently decreased BDNF expression in the PVN, as
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well as feeding and body weight. This is also true for food deprived animals (Wang et
al., 2007a & b). Additionally, BDNF infusion into the PVN increased energy
expenditure as a result of elevated resting metabolic rate (Wang et al., 2007a).
Deleting BDNF within the PVN leads to severe hyperphagia and obesity in mice as
well as decreased locomotor activity and decreased brown adipose tissue
thermogenesis (An et al., 2015).
Brain-Derived Neurotrophic Factor and Fasting
Consistent with these findings, fasting, which increases food intake, alters
BDNF expression in the hypothalamus. BDNF mRNA expression decreased in the
VMH in response to a 24 hour fast (Tran et al., 2006) or 48 hour fast (Xu et al., 2003;
Unger et al., 2007; Tran et al., 2006). In one experiment, animals were fasted for 48
hours and BDNF protein was measured analyzing the hypothalamus as a whole using
western blots and an enzyme-linked immunosorbent assay (ELISA). No significant
differences were observed in BDNF expression between the controls and the fasted
animals (Bariohay et al., 2005). It is important to determine BDNF expression within
the separate hypothalamic nuclei rather than the hypothalamus as a whole. It is
possible one nucleus could change in BDNF protein expression in one direction while
another nucleus change BDNF protein expression in the opposite direction. This could
result in no significant differences in protein changes between fed and fasted animals
as seen in the Bariohay et al., 2005 experiment. Therefore it is critical to investigate
each of the hypothalamic nuclei individually.
Research previously has been focused in the hippocampus looking at the effects
of WD and fasting on BDNF expression, probably because of BDNF’s role in learning
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and memory in the hippocampus. CA1 neurons of the hippocampus have projections
to areas of interest in this study, such as the PVN, VMH and ARC (Cenquizca &
Swanson, 2006) and BDNF could be transported to or from these areas. BDNF and
TrkB proteins are both highly expressed in the hippocampus. BDNF has been shown
to increase in the hippocampus in response to fasting whereas in the hypothalamus the
BDNF levels decrease (Duan et al., 2001).
Brain-Derived Neurotrophic Factor and Western Diets
WDs affect BDNF levels in the hippocampus of rats, by reducing BDNF levels
over two and twenty-four months (Molteni et al., 2002). One study in the hippocampus
measured BDNF protein levels in animals after consuming a diet high in saturated fats
for three weeks and found decreased BDNF levels in those animals (Sharma et al.,
2012). WD administration of 14 weeks significantly lowered BDNF mRNA levels, by
23% in the VMH-DMH and by 32-37% in the hippocampus in diet-induced obese
animals versus diet resistant animals. Diet-induced obese pair-fed animals also had
decreased BDNF mRNA expression, which was comparable to the decrease in the
unrestricted diet-induced obese animals. From this, it was proposed WD-induced
obesity could result due to a decrease in responsiveness to dietary related cues (Yu et
al., 2009).
Since the present study had begun, a new study has looked at the effects of WD
on BDNF mRNA expression over a short time period in the hypothalamus in male and
female rats. Female rats had a significantly higher amount of BDNF mRNA
expression than male rats regardless of the diet administered. Females also had higher
BDNF mRNA levels than males regardless of the amount of time in which they
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consumed the WD or control diet (Liu et al., 2014). This suggests females might be
protected from the effects of a WD on BDNF expression over short periods of time,
whereas males might be affected more strongly.
Both sexes of rats showed no differences in BDNF mRNA expression at four
days of WD consumption when compared to controls. Males increased body weight
and body fat mass during the four-day WD exposure but females did not. WD fed and
control female animals still had higher BDNF mRNA expression than males after four
days of feeding. At the end of the four week WD or WD pair fed (WD-PF) exposure,
males fed WD had significantly lower BDNF mRNA levels than controls. WD and
WD-PF did not differ significantly suggesting diet type and not overeating is
responsible for the decrease in BDNF mRNA levels. Female BDNF mRNA levels
remained similar after the four weeks, yet significantly higher than males (Liu et al.,
2014). However, earlier or later time points could exist where hypothalamic BDNF
expression could change due to WD therefore it is important to investigate more time
points as well as whether or not BDNF mRNA expression matches protein levels.
WDs have been used to study the effects on BDNF in the hypothalamus and
hippocampus. The goal behind the selection of the WD for the present study is twofold. First, it is important to replicate diets used in previous studies. This will help to
ensure an effect is seen and allows for some comparison. Secondly, a diet must be
selected to mimic a WD by containing high levels of fats and refined sugars and it must
cause the wild-type animal to become obese due to increased food intake (Hu et al.,
2001). A WD (or American diet) is typically defined as a diet containing at least 35%
fat, approximately 50% carbohydrates and 15% protein (Freedman et al., 2001). A
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common diet used when researching the effects of WDs on the hippocampus and
hypothalamus is based on the AIN-93G diet, which contains 39.5% kcal from fat,
39.5% kcal from carbohydrate and 21% kcal from protein. This diet contains sucrose
as the source of carbohydrates. Gomez-Pinilla and colleagues have used a very similar
diet in several experiments (Molteni et al., 2002; Molteni et al., 2004). Other diets
with slightly different compositions have also been used in BDNF expression studies.
These studies demonstrate WD effects on BDNF are not significantly altered due to
slight variations in fat content within the diets. A diet containing 45% fat by energy
caused animals to become obese and BDNF levels to drop in the hippocampus after
seven weeks on the diet (Park et al., 2010). Yu et al., (2009) used a slightly less fat
content of 40% fat but similar to Gomez-Pinilla and colleagues. Animals fed WD
gained more weight than those on a standard chow diet or animals who were diet
resistant. The diet selected for the current experiment was similar to diets used by
Molteni et al., (2004) and Yu et al., (2009) and contain a similar amount of fat and
carbohydrate content as used in other previous studies.
The control diet for this experiment will be a standard laboratory chow (Table
1). This diet type was selected over a diet which only differed in fat content for a
control diet because this study is not aimed to investigate what nutrients are important
for producing obesity, but is more focused on the difference in energy consumption,
which supports obesity. Standard chow has also been used as the control diet in the
majority if not all of studies of the changes of BDNF expression in the brain of animals
on a WD. Animals have also been maintained on this diet since birth and eliminating
any changes in diet type will reduce possible confounds.
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Aims
The aims of the present study are to investigate whether the reduction of BDNF
mRNA in the VMH is mirrored by a reduction in BDNF protein in fasted mice and to
determine if there are similar decreases in BDNF protein in response to a WD over a
period of time of three weeks or less.
In the past, little research has examined the long-term effects of WDs on the
hypothalamus and has focused particularly in the area of the VMH. Over time, when
WDs are consumed, cells in these areas of the brain have decreased BDNF levels (Xu
et al., 2003; Yu et al., 2009). Time courses investigated with these WDs have been
four weeks or longer. However, BDNF protein expression needs to be investigated on
a shorter time course to determine when these changes begin to occur within the
different hypothalamic nuclei. This study hypothesizes mice consuming diets
containing a large percentage of saturated fats and refined sugars, similar to a WD, will
mirror BDNF mRNA studies and show decreased BDNF protein expression in the
VMH, PVN and ARC nucleus in the short-term, which will be defined as anything less
than or equal to three weeks.
This study will specifically look at BDNF protein immunohistochemistry in the
hypothalamus in response to fasting and WD to compliment and replicate the results of
earlier fasting studies which looked at mRNA expression and to further research the
effects of WDs on BDNF in the hypothalamus. It is also important to investigate these
effects in the PVN and ARC as well as in the VMH as they have received very little
attention despite their significance for the control of food intake and body weight. In
order to test the proposed hypothesis, two experiments were performed: the effects of
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fasting on BDNF-IR cell number in the hypothalamus and the effects of WD on
BDNF-IR cell number in the hypothalamus.
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METHODS

Animals
Wild-type, three to five month old, male C57BL/6 mice were used and kept at
normal lab conditions. Harlen Industries of Indianapolis originally provided these
mice and they have been bred for several generations in our lab. Animals were kept on
a 12:12 hour light/dark cycle with the lights turning off at 2pm and turning on at 2am
for a minimum of two weeks before the start of the experiment. Food intake and body
weight were measured just before 2pm daily.
Diets
Two diets were used throughout this experiment: The powdered Western Diet
for Rodents (5TJN, TestDiet #1810850), which contains approximately 39.9% fat,
44.1% carbohydrate (sucrose) and 16.3% protein and has an energy density of 4.49
kcal/g (Table 1). The powdered chow diet (Laboratory Rodent Diet 5001) contains
13.50% fat, 58.00% carbohydrates and 28.51% protein and has an energy density of
3.34 kcal/g (Table 1).
Experiment 1: The Effects of Feeding and Fasting on BDNF-IR Cell Number
in the ARC, VMH, PVN and CORTEX
For all experimental runs, animals were housed individually. Animals were run
in pairs, one control animal (FED) and one fasted animal (FAST) in order to account
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for any variation between runs due to unintended differences in procedures or lab
environment. Twenty animals were divided into two groups, however three FED and
two FAST animals were dropped because they did not meet criteria for counting (see
Quantification) for a final group size of eight FAST and seven FED. Food intake and
body weight were measured daily. Stable food intake was defined as: when the mouse
consumed + 1g each day for five days in a row of the average intake for those five days
(Byerly and Fox, 2006). Groups were divided so that body weight and food intake did
not differ between the groups. Days 1-5 of the experiment were the five days of stable
food intake followed by feeding or fasting on days 6-7. The FED group was fed
standard chow for 48 hours while the FAST group was without food for 48 hours.
Food was removed at 2pm and animals were perfused 48 hours later.
Tissue Processing
All animals were perfused at 2pm just before the light cycle changed to lights
out. Mice were given a lethal dose of Brevital Sodium (sodium methohexital; 100
mg/kg) before perfusion. Animals were perfused transcardially using a rate of 4ml/min
of room temperature saline for ten minutes and 4% paraformaldehyde, kept on ice,
made in 0.1M sodium phosphate buffered saline (PBS) for thirty minutes. Whole
brains were extracted and stored at 4˚C in 4% paraformaldehyde made in PBS
overnight. Brains were prepared for freezing by storing them in a 30% sucrose
solution made in PBS overnight at 4˚C. The brains were blocked to contain the
hypothalamus and frozen in liquid nitrogen. A beaker containing 50mL of isopentane
was cooled in the liquid nitrogen until it began to freeze. The tissue was placed in a
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plastic mold filled with Tissue Tek O.C.T. and placed in the near frozen isopentane
until frozen. The brain blocks were stored at -80˚C and saved for frozen for sectioning.
Immunohistochemistry
First, a control brain was cross-sectioned at 30

m through the VMH, PVN and

ARC to use as a reference for landmarks to aid location of sections used for counting in
animals. These sections were stained with 0.02% cresyl violet. Experimental brain
sections were taken through the hypothalamus, focusing on the sections containing the
VMH, PVN and ARC using a section thickness of 30

m yielding approximately 50

sections. In all animals, every ninth section was saved for cresyl violet staining. These
cresyl violet sections in each animal also helped to determine the shape of each
nucleus, and location of brain region borders. The remaining eight of nine sections
were immunostained for BDNF. The staining protocol was similar to that of Ewa et
al., (2012). Sections were stained using the free-floating technique with slight agitation
during the entire immunostaining procedure to ensure even staining. Sections were
first taken through three PBS washes at fifteen minutes each. They were incubated in
2mL of goat block (1.5% normal goat serum, 0.5% Triton X-100, 2% BSA), for one
hour. After the block, the primary antibody for BDNF (primary rabbit anti-BDNF
polyclonal antibody, Millipore-Chemicon, AB1534SP) was diluted in goat diluent to a
final concentration of 1:1500 for three days. During this time the sections were kept at
4˚C. Next, the sections were taken through three PBS washes at fifteen minutes each.
Then the secondary antibody, Cy3 (Cy3-conjugated goat anti-rabbit, Jackson
ImmunoResearch, 111-165-144), was diluted with goat diluent and applied at a
concentration of 1:600 for two hours. The sections were kept in the dark to prevent a

14
decrease in the fluorescence and were kept at 4˚C during this incubation. Finally, the
sections were washed in PBS three times at fifteen minutes each. The sections were
mounted on slides in glycerol, sealed with clear nail polish and stored at 4˚C in the
dark until confocal imaging and quantification.
The specificity of the primary antibody was also tested. The same procedures
were followed, except the primary antibody was replaced with goat diluent. Slides
were examined afterwards to look for stained cells and non-specific binding. Ewa et
al., (2012) also tested the specificity of this antibody for BDNF using western blots on
tissues taken from the hypothalamus and hippocampus. Specific binding with bands at
18kDa for mature BDNF protein and at 30kDa for precursor BDNF was demonstrated.
Quantification
Sections were viewed using a fluorescent microscope and areas that were
counted included the VMH, PVN, ARC and a control cortex region, the ectorhinal
cortex. The cortex has previously shown no changes in BDNF mRNA expression in
response to fasting (Xu, 2003; Tran, 2006), however BDNF protein has not been
quantified in the cortex in the previous studies. A control area in each section was also
counted. This area was the ectorhinal cortex and was chosen due to the ease of
anatomical identification. The numbers of cells in each brain region of interest were
quantified.
Slides were coded so the sections were counted blindly to prevent biased
counting. In order for quantification of cells in an area to occur, criteria had to be
reached to ensure the quality of the sections. First, the cortex must be intact and not
folded in the areas counted. Second, the tissue must be intact in areas counted with no
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areas of the tissue missing. Third, there must be no obvious right to left or top to
bottom staining gradients as a result of uneven staining.
An Olympus BX-DSU spinning disk confocal microscope was used to image
each nucleus using a Hamamatsu 1394 ORCA-ERA SIN 660671 camera at a
magnification of 100X. An AL594 filter was used to take images. Images were taken
using 3-dimensional capture in 1μm steps through 21μm sections of tissue at 5000ms
exposure per step. The cells in each nucleus were imaged in the order of left ARC,
right ARC, left VMH, right VMH, left PVN, right PVN, left control cortex and right
control cortex based on the orientation of the section on the slide. The most clearly
focused 1 μm z-plane confocal image (cells in sharpest focus across the entire imaged
portion of the section) was identified and used for analysis. See Figures 1 & 2 for a
sample of images collected.
Single plane images were then analyzed using Image J (National Institute of
Health, Version 1.48 for Mac OSX 10.5.) Images were adjusted to an 8-bit image and
then inverted. Background was removed using a 50.0 pixel rolling ball radius. Images
were then converted to a binary image and noise was removed using the despeckle
feature. Each nucleus was outlined based on cresyl violet sections and The Mouse
Brain Atlas (Paxinos & Franklin, 2008). Cells were counted using the analyze particle
settings. These methods were adapted from Image J: Area Measurements and Particle
Counting Tutorial & Examples (Reinking, 2007). The area of CORTEX was imaged
by lining up the bottom of the ectorhinal cortex with the bottom of the image frame.
The outer most area of the second layer of the cortex was then aligned with the vertical
image frame. The entire area imaged was then counted. Three sections from each
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animal and in each nucleus were counted. For each brain region quantified, BDNF-IR
cell number were counted in both right and left sides of the brain and summed. See
Figure 3 for sample count image.
Analysis
Values reported are means + SEM. Statistica (v5.0, StatSoft, Tulsa, OK) and
GraphPad Prism (version 4.0; GraphPad Software) were used for all statistical tests and
graphs. In all statistical analysis, p < 0.05 is considered significant results. The first
measures were body weight and food intake for FED and FAST groups. These
measures were analyzed using a student’s unpaired t-test. The independent variable
was the diet condition (FED or FAST) and the dependent variable was the food intake
in kilocalories (kcal), or body weight in grams. Statistical analysis was performed
using a student’s unpaired t-test differences in BDNF-IR cell number between each of
the FED and FAST groups in the VMH, PVN and ARC and CORTEX. The
independent variable was the time exposed to each diet condition and the dependent
variable was the BDNF-IR cell count within each brain region.
Experiment 2: The Short-Term Effects of WD on BDNF-IR Cell Number
in the ARC, VMH, PVN and CORTEX
Pre-Test Diet Exposure
For all trials, animals were housed individually. During the habituation period
powdered chow was administered in 2 oz. spill proof glass jars (Unifab, Kalamazoo,
MI, USA). Food intake and body weight were measured daily. Once food intake
stabilized, as defined in Experiment 1, all animals received WD overnight for fifteen
hours to prevent neophobia on initial test diet exposure and food intake was measured
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during the exposure. Animals were then returned to powdered control chow for two
weeks to minimize any potential effects of this WD pre-exposure on BDNF-IR cell
counts. See Figure 4a for graphical representation of the experiment design.
Test Diet Exposure
Animals were assigned duration of test diet exposure of either: six-hours (n =
21), forty-eight hours (n = 29), one-week (n = 30) and three-weeks (n = 27). This is
how long the animal received their diet before being sacrificed. Animals were divided
into experiment groups based on food intake and body weight measurements taken
during the period of stable food intake and body weight. The animals were divided
into duration of test diet exposure groups: 6-hours, 48-hours, 1-week and 3-weeks and
then divided further into three test diet duration groups: WD, WD-FR or CHOW (n =
7-9/group; see Figure 4b for duration, test diet exposure and sample size) except for the
six hour group which was just divided into WD and CHOW. The WD group received
the powdered WD diet ad libitum during the test diet exposure. Fresh WD was given
at a minimum of every three days as recommended by TestDiets to maintain the
integrity of the diet. The WD-FR group received the powdered WD in an equal
amount of calories to the average amount of chow consumed by the powdered chow
control group during the five-day period of stable food intake. The CHOW group
received powdered chow ad libitum during the test diet exposure. In order for animals
to be included in analysis in the present study, they must have consumed at least as
much of their assigned diet during their test diet exposure duration as the lowest
amount (in kcal) of food consumed in one day during the period of stable food intake
daily. Six-hour diet duration exposure animals must have consumed 25% of the lowest
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amount (in kcal) of food consumed in one day during the period of stable food intake.
The food was given and animals had access to the food for the entire time group they
were assigned. Animals were sacrificed at 2pm just before the light cycle changed to
the dark cycle of the day. All animals were perfused at the end of the exposure
duration within + 1 hr of the end of the test diet exposure duration. Tissue preparation,
immunohistochemistry and quantification were identical as in Experiment 1. Animals
were also processed in groups of three; one WD, one WD-FR and one CHOW mouse
from the test diet exposure duration group. Eleven animals were dropped from the
study due to sections not meeting criteria (as outlined in the quantification section).
Two were dropped from the 6-hour group (1 WD, 1 CHOW), three from the 48-hour
group (1 WD, 1 WD-FR, 1 CHOW), five from the 1-week group (1 WD, 2 WD-FR, 2
CHOW) and one from the 3-week group (1 WD). Cell counts that were outside of two
standard deviations from the mean of their group were also excluded from analysis.
Three animals from the 6-hour group (1 WD, 1 WD-FR, 1 CHOW), two from the 48hour group (1 WD, 1 WD-FR) and three from the 1-week group (1 WD, 1 WD-FR, 1
CHOW), were excluded as outliers. See Figure 4b for final group sizes.
Analysis
Values reported are means + SEM. Statistica (v5.0, StatSoft, Tulsa, OK) and
GraphPad Prism (version 4.0; GraphPad Software) were used for all statistical tests and
graphs. In all statistical analysis, p< 0.05 is considered significant results. The first
measures were body weight and food intake for animals on their diets in each test diet
exposure duration group. These measures were analyzed using a one-way ANOVA.
The independent variable was the diet condition (WD, WD-FR and CHOW) and the
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dependent variable was the food intake in kilocalories (kcal), or body weight in grams.
Statistical analysis was performed using a student’s unpaired t-test to compare BDNFIR cell number between each of the WD, WD-FR & CHOW groups in the VMH, PVN
and ARC and CORTEX. The hypothesis was animals consuming WD and WD-FR
would decrease compared to the CHOW in the ARC, VMH and PVN; no changes were
hypothesized in the CORTEX. The independent variable was the time exposed to each
diet condition and the dependent variable was the BDNF-IR cell count within each
brain region. Repeated measures ANOVA were used to analyze food intake and body
weight patterns in the one-week and three-week groups. Repeated measures pairwise
comparisons were made between test diet groups if overall repeated measures ANOVA
was significant.
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RESULTS

Experiment 1: Effects of Fasting on Hypothalamic BDNF-IR Cell Number
Food Intake and Body Weight
No differences in average daily food intake (15.58 + 0.45 kcal FED, 14.98 +
0.66 kcal FAST; p = 0.3343) or body weight (24.67 + 0.59g FED, 24.22 + 0.43g
FAST; p = 0.2666) between all animals were observed during the period of stable food
intake of the experiment (days 1-5). Food intake for FED animals was approximately
15.58 + 0.65 kcal/day during the experiment (days 6-7). FAST animals received no
food and thus their food intake was 0 kcal/day (Figure 5a, b). Body weight decreased
significantly by 13% after 24 hours and 21% after 48 hours (p < 0.01) in the FAST
group of animals. Body weight for the FED group after 48 hours was 24.94 + 0.52g.
Body weight for the FAST group after 48 hours was 20.67 + 0.52g (Figure 5c, d).
Cell Counts
Cell counts were analyzed in the ARC, VMH, PVN and CORTEX. Mean cell
counts in the ARC were 122.19 + 16.71 (FED) and 83.58 + 12.45 (FAST). The FAST
animals showed decreased BDNF-IR cell number compared to FED animals in the
ARC by 32% (p < 0.05). Mean cell counts in the VMH were 494.14 + 55.82 (FED)
and 398.00 + 74.40 (FAST). There was a near-significant decreasing trend in the VMH
(26.76%; p = 0.0932). Mean cell counts in the PVN were 208.70 + 24.91 (FED) and
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164.10 + 26.32 (FAST), which was not significant (p = 0.1221). Mean cell counts in
the CORTEX were 990.42 + 63.21 (FED) and 972.90 + 91.66 (FAST), which were
also not significant (p = 0.2661) (Table 3; Figure 5e).
Experiment 2: Effects of WD on Hypothalamic BDNF-IR Cell Number
6-Hour Test Diet Exposure
During the period of stable food intake, animals consumed 15.49 + 0.26
kcal/day (WD) and 15.49 + 0.43 kcal/day (CHOW) (p = 0.9845) and weighed 25.09 +
0.30g (WD) and 25.56 + 0.28g (CHOW) (p = 0.5072). The day prior to test diet
exposure animals did not differ in body weight (p=0.4491) or food intake (p = 0.4979).
See Table 2 for group means. Animals ate significantly less during the six-hour test
diet exposure than what was eaten during a normal twenty-four hour period. During
test diet exposure, the WD animals ate more (11.97 + 0.38 kcal) than the CHOW
animals (8.08 + 0.60 kcal) (p < 0.01). Both groups ate significantly less than they did
on the day prior to test diet exposure (p < 0.01) (Figure 6a). Body weight was not
different between the WD (26.79 + 0.54g; p = 0.0799) and CHOW (26.64 + 0.78g; p =
0.1984) groups after test diet exposure when compared to the day prior to test diet
exposure (Figure 6b).
No differences in any of the brain areas were observed at this time point
between the two diet groups. Mean cell counts in the ARC were: 156.77 + 19.20 WD
and 130.19 + 12.87 CHOW (p = 0.1423). Mean cell counts in the VMH were: 522.94 +
72.81 WD and 487.19 + 42.47 CHOW (p = 0.3451). Mean cell counts in the PVN
were: 231.50 + 20.03 WD and 253.96 + 31.79 CHOW (p = 0.2798). Mean cell counts
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in the CORTEX were: 1323.93 + 75.59 WD and 1359.33 + 64.15 CHOW (p = 0.3628)
(Table 4; Figure 6c).
48-Hour Test Diet Exposure
During the period of stable food intake, animals consumed 14.19 + 0.31
kcal/day (WD), 14.89 + 0.44 kcal/day (WD-FR), and 15.13 + 0.36 kcal/day (CHOW)
(p = 0.2094) and weighed 24.05 + 0.09g (WD) and 23.65 + 0.13g (WD-FR) and 24.46
+ 0.14g (CHOW) (p = 0.3201). The day prior to test diet exposure animals did not
differ in body weight (p = 0.3936) or food intake (p = 0.9456). See Table 2 for group
means. During the test diet exposure period, the WD group ate significantly more
(18.27 + 0.72 kcal/day) than during the day prior to test diet exposure and more than
the WD-FR (13.61 + 0.37 kcal)/day and CHOW (14.95 + 0.54 kcal/day) groups during
the test diet exposure period (all p < 0.01). WD-FR animals increased food intake
during test diet exposure from the day prior to test diet exposure (p < 0.05) while the
CHOW animal’s food intake remained the same between the period of stable food
intake and test diet exposure (p = 0.4997) (Figure 7a). After test diet exposure, body
weights for the groups were: 25.44 + 0.78g WD, 24.83 + 0.78g WD-FR and 24.93 +
0.43g CHOW (p = 0.3201) (Figure 7d). There were no changes in body weight
between the day prior to test diet exposure and after test diet exposure (WD, p =
0.0570; WD-FR, p = 0.1384; CHOW, p = 0.2494).
Mean cell counts were not significantly different in any brain area between the
groups at this time point. Mean cell counts in the ARC were: 108.71 + 14.70 WD,
116.75 + 17.60 WD-FR, and 101.27 + 19.19 CHOW (p = 0.3841). Mean cell counts in
the VMH were: 517.81 + 55.71 WD, 414.52 + 30.85 WD-FR, and 388.65 + 57.80
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CHOW. ). There was a near-significant increasing trend within the VMH by 20% (p =
0.0671). Mean cell counts in the PVN were: 223.83 + 9.91 WD, 224.44 + 22.31 WDFR, and 239.33 + 18.13 CHOW (p = 0.2423). Mean cell counts in the CORTEX were:
1102.73 + 104.41 WD, 1088.60 + 58.60 WD-FR, and 930.53 + 74.22 CHOW There
was a near-significant increasing trend between WD vs. CHOW and WD-FR vs
CHOW within the CORTEX. The WD was increased over CHOW by 16% (p =
0.0952) and the WD-FR was increased over the CHOW by 14.5% (p = 0.0510) (Table
4; Figure 7c).
1-Week Test Diet Exposure
During the period of stable food intake, animals consumed 14.71 + 0.32
kcal/day (WD), 14.66 + 0.38 kcal/day (WD-FR), and 14.83 + 0.28 kcal/day (CHOW)
(p = 0.9253) and weighed 25.55 + 0.32g (WD), 24.63 + 0.38g (WD-FR) and 24.33 +
0.19 g (CHOW) (p = 0.3275). The day prior to test diet exposure animals did not differ
in body weight (p = 0.5863) or food intake (p = 0.7688). See Table 2 for group means.
When food intake was averaged over the entire week of test diet exposure, the WD
group ate 18.85 + 0.61 kcal/day, which was significantly more than the WD-FR (15.31
+ 0.77 kcal/day) (p < 0.01) and CHOW (14.35 + 0.48 kcal/day) (p < 0.01) groups
(Figure 8a, c). Food intake for the WD group was significantly increased from the
stable food intake at the completion of test diet exposure (p < 0.01) whereas food
intake for WD-FR (p = 0.2362) and CHOW (p = 0.2102) groups remained the same.
Food intake was also increased from the day prior to test diet exposure in the WD
group (p < 0.01) but not in the WD-FR (p = 0.3821) or in the CHOW (p = 0.4540)
groups. When body weights were averaged over the week for the three groups, the
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WD group (28.74 + 1.27g) still maintained a significantly higher body weight than the
WD-FR (25.94 + 1.21g) and CHOW groups (25.94 + 0.78g) (p < 0.05) (Figure 8b, d).
Body weight was significantly increased in the WD from the day prior to test diet
exposure compared to after test diet exposure (p < 0.05). Body weight remained the
same for the WD-FR (p = 0.1966) and CHOW (p = 0.0675) groups. Repeated
measures analysis showed significant differences between food intake in the main
effects (diet and days) and interaction (days*diet) (p < 0.01) during test diet exposure
between the WD, WD-FR and CHOW groups. Repeated measures pairwise
comparisons between food intake showed differences between WD vs. WD-FR and
WD vs. CHOW (p < 0.01) but no difference between WD-FR vs. CHOW (p = 0.2728).
Repeated measures analysis showed significant differences between body weight in the
main effect days (p < 0.01) but not diet (p=0.1292) and significant interaction
(days*diet) (p < 0.01) during test diet exposure between the WD, WD-FR and CHOW
groups. Repeated measures pairwise comparisons between body weight showed
differences between WD vs. WD-FR, WD vs. CHOW (p < 0.01) and WD-FR vs.
CHOW (p < 0.05).
Mean cell counts in the ARC were: 95.73 + 12.81 WD, 81.33 + 20.13 WD-FR,
and 104.00 + 12.14 CHOW. No differences were observed in this brain area at this
time point (p = 0.3354). Mean cell counts in the VMH were: 502.75 + 44.12 WD,
340.00 + 58.06 WD-FR, and 359.17 + 45.42 CHOW. Mean cell counts were 29%
higher in the WD group within the VMH compared to the CHOW group (p < 0.05) and
32% higher compared to the WD-FR group (p < 0.05). Mean cell counts in the PVN
were: 242.71 + 32.73 WD, 224.881 + 23.09 WD-FR, and 218.45 + 38.31 CHOW. No
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differences were observed in this brain area at this time point (p = 0.3180). Mean cell
counts in the CORTEX were: 1140.01 + 97.08 WD, 1011.36 + 57.56 WD-FR, and
948.12 + 37.42 CHOW. Mean cell counts were 17% higher in the WD group within
the CORTEX compared to the CHOW and 11% higher than the WD-FR groups (p <
0.05) (Table 4; Figure 8e).
3-Week Test Diet Exposure
During the period of stable food intake, animals consumed 14.73 + 0.23
kcal/day (WD), 13.89 + 0.22 kcal/day (WD-FR), and 14.62 + 0.28 kcal/day (CHOW)
(p = 0.0531) and weighed 23.84 + 0.29g (WD) and 24.09 + 0.31g (WD-FR) and 23.73
+ 0.35 g (CHOW) (p = 0.7120). The day prior to test diet exposure animals did not
differ in body weight (p = 0.9136) or food intake (p=0.0933). See Table 2 for group
means. When food intake was averaged for the three-week test diet exposure, WD
group (15.78 + 0.77 kcal/day) food intake was not significantly different from the
CHOW group (16.16 + 0.93 kcal/day) (p = 0.3787). However, the food intake in the
WD-FR groups (13.21 + 0.49 kcal/day) was significantly less than the other two groups
(p < 0.05) (Figure 9a, b). WD-FR animals did not always consume all of the food they
were given. When food intake was compared between the day prior to test diet
exposure and food intake during the test diet exposure, the WD group and WD-FR
groups increased food intake (WD p < 0.05; WD-FR p < 0.01). The CHOW group did
not alter their food intake between the day prior to test diet exposure or during the test
diet exposure period (p = 0.2345). When body weight was averaged across the threeweek exposure, the body weights did not differ (WD 26.46 + 1.23g; WD-FR 26.07 +
1.10g; and CHOW 24.46 + 0.63 g; p=0.3340) (Figure 9c, d). When body weight was

26
compared to body weight during the day prior to test diet exposure, body weight was
increased in the WD (p < 0.05) but remained the same in the WD-FR (p = 0.1021) and
in the CHOW (p = 0.3879). Repeated measures analysis showed significant
differences between food intake in the main effects days (p < 0.01) but not diet (p =
0.3697) and interaction (days*diet) (p < 0.01) during test diet exposure between the
WD, WD-FR and CHOW groups. Repeated measures pairwise comparisons between
food intake showed differences between WD vs. CHOW and WD-FR vs. CHOW (p <
0.01) but no difference between WD vs. WD-FR (p = 0.0580). Repeated measures
analysis showed significant differences between body weight in the main effects (diet
and days) (p < 0.01) and interaction (days*diet) (p < 0.01) during test diet exposure
between the WD, WD-FR and CHOW groups. Repeated measures pairwise
comparisons between body weight showed differences between WD-FR vs. CHOW
and WD vs. CHOW (p < 0.01) and no differences between WD vs. WD-FR (p =
0.9735).
No significant differences were observed in any of the brain areas between the
diets groups. Mean cell counts in the ARC were: 165.58 + 23.44 WD, 141.63 + 13.09
WD-FR, and 146.13 + 11.32 CHOW (p = 0.2251). Mean cell counts in the VMH were:
534 + 42.65 WD, 538.96 + 51.51 WD-FR, and 507.65 + 41.79 CHOW (p = 0.3330).
Mean cell counts in the PVN were: 241.46 + 24.84 WD, 292.11 + 17.91 WD-FR, and
282.00 + 11.64 CHOW (p = 0.0728). Mean cell counts in the CORTEX were: 1312.48
+ 65.11 WD, 1431.37 + 71.16 WD-FR, and 1271.89 + 58.98 CHOW (p = 0.3232)
(Table 4; Figure 9e).
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GENERAL DISCUSSION
In most areas of the brain, mRNA BDNF expression increases in response to
fasting, however, in the VMH, BDNF mRNA expression decreases in response to
fasting (Tran et al., 2006; Xu et al., 2003; Unger et al., 2007). In this study, BDNF-IR
cell numbers decreased in the ARC in response to fasting and showed a non-significant
decreasing trend within the VMH. These findings are consistent with the hypothesis
BDNF is a satiety molecule tied to nutritional state. As nutrition decreases within an
animal so does the BDNF-IR cell number within the hypothalamus, specifically within
the ARC. Previous studies have seen decreases in BDNF mRNA within the VMH in
response to fasting (Tran et al., 2006; Xu et al., 2003; Unger et al., 2007). Within this
study there was failure to observe significant BDNF-IR decreases within the VMH,
however there was a non-significant decreasing trend. It is possible VMH BDNF
mRNA levels decrease faster than VMH BDNF-IR cells and longer fasting may be
required in order to observe decreases in VMH BDNF-IR cell number.
BDNF has been shown to be anterogradely transported throughout the brain
(Altar et al., 1997; Tonra, 1999). It is possible BDNF protein is being transported from
the VMH to the ARC because there is no evidence for BDNF mRNA being produced
within the ARC (Conner et al., 1997). This could explain why decreases were seen in
the ARC but not in the VMH at this time point. Protein from the VMH was no longer
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transported to the ARC in an effort to maintain levels within the VMH and therefore
BDNF protein does not mirror BDNR mRNA. BDNF protein in the VMH may still
decrease but BDNF protein does not directly match the time course of BDNF mRNA
in response to fasting.
It is also possible that the microcircuits within the VMH and ARC are
reorganizing. Sternson et al., 2005 has shown that fasting decreased signaling from
excitatory VMH neurons to proopiomelanocortin (POMC) arcuate neurons compared
to fed mice. They were also able to demonstrate plasticity within these neurons
(Sternson et al., 2005). Liao et al., 2015, demonstrated that 16.5% of POMC arcuate
neurons express the BDNF receptor, TrkB. Therefore, it is possible that BDNF
expression is decreasing due to reorganization of the microcircuit between the VMH
and ARC.
WD animals show an increase in BDNF-IR cell number when compared to
animals fed a WD-FR or CHOW diet within the VMH and CORTEX at the one-week
time point. Over the experimental time course, BDNF-IR cell number first began with
a non-significant increase in the VMH and CORTEX at 48 hours and then became
significant at one week. BDNF-IR cell number in the VMH and CORTEX returned to
the levels of WD-FR and CHOW animals by three weeks of test diet exposure. Body
weight and food intake were also significantly higher in WD fed animals at one week
compared to WD-FR and CHOW suggesting that changes in both food intake and body
weight might be necessary for changes in BDNF-IR cell numbers. This was also true
for animals fasted for 48 hours. There was a significant decrease in both food intake
and body weight resulting in decreases in ARC BDNF-IR cell numbers.
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The simplest explanation for an increase in BDNF-IR within the VMH at one
week on WD ad libitum is an attempt to inhibit food intake. Food intake increased and
BDNF-IR cell number could increase in an attempt to prevent overeating and decrease
food intake in the short-term. BDNF-IR cell number could initially start to increase
when overeating first occurs and continue to increase until the overeating is finally
inhibited. WD feeding would cause leptin to increase within the body and BDNF
mRNA has been shown to increase within the VMH as leptin increases within the
hypothalamus in the short-term (Komori et al., 2006). It is possible that leptin is acting
directly on the neurons within the VMH because the VMH expresses the leptin
receptor or indirectly by leptin increasing the production of a-melanocyte (a-MSH)
stimulating hormone within the ARC and a-MSH and activates the melanocortin 4
receptor (MC4R) within the VMH, which then activates BDNF expression (Komori et
al., 2006; Xu et al., 2003). Long-term consumption of WD leads to leptin resistance
(Lin et al., 2000) and BDNF mRNA expression also decreases in response to long-term
WD consumption (Yu et al., 2009) further supporting leptin is impacting BDNF
expression within the hypothalamus.
Increases in BDNF-IR cell number within the CORTEX were unexpected.
BDNF-IR cell number within the CORTEX did not change in response to fasting but
increased in response to a one- week WD. The ectorhinal cortex provides neocortical
input to the hippocampus (Eichenbaum, 2000) and it is possible the effects of WD on
BDNF in the hippocampus could affect the BDNF levels in the CORTEX through
anterograde transport (Altar et al., 1997; Tonra, 1999). The ectorhinal cortex also has
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connections with autonomic pathways and specifically the celiac ganglion, which could
possibly influence eating or body weight (Westerhaus and Loewy, 2001).
Increases in BDNF have been shown to occur within the brain in response to
pain, nerve injury and inflammation. For example, in rats, which had higher levels of
BDNF in the hippocampus, induced seizures had less of a damaging effect on the brain
(Kuramoto et al., 2011). Inflammation as a result of obesity within the hypothalamus
has been demonstrated multiple times (De Souza et al., 2005; Cai & Liu, 2011; Thaler
et al., 2011). Administration of a WD for 24 hours showed inflammation in the nodose
ganglion, hypothalamus and the gut of mice (Zaved Waise et al., 2015). Since WD
administration for 24 hours and even potentially less time causes inflammation, it could
be hypothesized that the reason for increased BDNF-IR cell number within the
hypothalamus is due to BDNF’s protective effect in response to the inflammation.
Increases in BDNF in some areas of the brain have prevented cell death (Almedia et
al., 2005). Schwartz and colleagues saw hypothalamic inflammation from one to three
days on a high fat diet and were able to demonstrated neuron injury in the arcuate after
one-week of high fat diet feeding. (Thaler et al., 2011). C57BL/6 mice showed
hypothalamic proinflamitory gene expression was also activated within the first seven
days of high fat diet exposure and returned to baseline levels between seven and
fourteen days on high fat diet (Thaler et al., 2011). Since there is evidence for
inflammation within the hypothalamus in the short-term on a high fat diet and that
BDNF tends to increase in other areas of the brain due to inflammation it is possible
that BDNF-IR cell numbers are increasing in response to inflammation within the
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VMH at the one-week time point. This might also explain the trend of increasing
BDNF-IR cell numbers at the 48-hour time point within the VMH.
It is also possible that BDNF is acting in multiple ways within the different
nuclei of the hypothalamus. It could be acting as a satiety molecule responding to a fed
or fasted nutritional state while also having neuroprotective functions within the same
areas of the hypothalamus when exposed to a WD. Future studies should test
inflammation levels and BDNF levels to see if there is a correlation between the two.
The present study and literature would suggest BDNF within the hypothalamus
increases in response to inflammation in at least the first seven days of WD feeding.
The literature would also suggest that BDNF expression is decreased during
inflammation within the hypothalamus after one month or longer of WD feeding. An
important control for this experiment would be to have a control animal with
inflammation not due to a WD. This way, the inflammatory response and satiety
response could begin to be separated.
Determining intensity of BDNF expression within cells is an important future
experiment. Sometime points may show increased or decreased intensity of BDNF
protein within cells and not necessarily an increase or decrease in cell numbers. This
might be especially true at earlier time points because either nearby cells have not been
signaled to express BDNF or may not have been signaled to express detectable levels
of BDNF. Number of BDNF-IR cells as well as intensity as a measurement of protein
within the cells could also be important. Therefore, original confocal images will be
analyzed for changes in intensity. It could be possible BDNF-IR cell numbers increase
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and BDNF intensity could increase or decrease. It is also possible there could be
changes in BDNF intensity without seeing changes in BDNF-IR cells.
Another unanswered question is whether or not the increase in cell number
within the VMH and CORTEX is due to cells increasing their expression of BDNF to
detectable levels or because there are more cells in each of these nuclei, suggesting
neurogenesis has occurred. BDNF has been previously shown to increase neurogenesis
within the hypothalamus (Pencea et al., 2001) so it is possible new neurons were
generated within the VMH and CORTEX in response to increased levels of BDNF.
Cresyl violet sections will be counted. These experiments may show other differences
at other time points where there was not a difference in BDNF-IR cell counts between
diet groups.
Another critical future experiment will be to test if there are changes in BDNFIR cell numbers when looking at specific cell types. Recently, within the ARC, a new
class of neurons was described which expressed the BDNF receptor, TrkB, but not
POMC or neuropeptide Y (NPY) (Liao et al., 2015). Only 30% of neurons which
expressed TrkB also expressed POMC or NPY and TrkB is not ever expressed on
GABAergic Rip-Cre neurons (Liao et al., 2015). This would suggest some neurons
might be more greatly affected by changes in BDNF expression while others are not.
If the receptor for BDNF is not on a neuron type it is possible that no change in BDNFIR cell numbers would be seen for those classes of neurons whereas if TrkB is more
abundant on other cell types there could be very dramatic changes in BDNF-IR cell
numbers. Cell heterogeneity within the ARC, VMH and PVN could have caused
failure to observe differences in BDNF-IR numbers. ARC TrkB neurons also appear to
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be activated by nutritional state (Liao et al., 2015), which could explain a decrease in
ARC BDNF-IR cell number after 48-hour fast.
Another important experiment to perform will be to investigate sex differences
at the protein level. Liu et al., 2014 showed dramatic sex differences in BDNF mRNA.
It will be important to determine if protein levels change within females in response to
a WD or if the levels of protein will be maintained similar to mRNA levels after a WD.
It will also be important to know whether or not BDNF protein levels are higher within
females compared to males as they have increased BDNF mRNA levels compared to
males (Liu et al., 2014).
In the future, it will also be necessary to measure BDNF protein and mRNA
within the same study to ultimately determine if BDNF protein mirrors mRNA and if it
is over a similar time course. Liu et al., 2014 saw no differences in VMH mRNA after
a WD exposure of four days. In the present study, no differences in protein were seen
within the VMH at the 6-hour and 48-hour time points, the time points prior to the 4day time point. Increases were then seen in this study at the 1-week time point within
the VMH and CORTEX. These increases return to baseline levels by the 3-week time
point. The Liu et al., 2014 study then saw decreases in BDNF mRNA levels after a
four week WD exposure. These changes are also consistent with the known time
course of leptin resistance. After initial exposure to WD, leptin increases (Lin et al.,
2000) and BDNF protein increases around the 1-week time point. Leptin resistance
has been shown to occur around 4 weeks of WD exposure (Zhang et al., 2015) and it is
possible BDNF decreases in response to leptin resistance.
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In conclusion these results show decreased ARC BDNF-IR cell number in
response to a 48-hour fast and increased BDNF-IR cell counts at one week WD
exposure within the VMH and CORTEX. BDNF-IR cell counts within the VMH
might still decrease however; it is probable a slightly longer fast is necessary to see
decreases in the VMH. Increases in BDNF-IR cell counts could have occurred in an
attempt to inhibit feeding and moderate weight gain in the WD group since there were
no differences in the WDFR and CHOW groups. This suggests that the components of
the diet do not influence BDNF-IR cell counts as much as overeating influences
BDNF-IR cell counts in the short-term. BDNF-IR cell intensities are being measured
to determine if protein levels are different even though cell numbers are not different.
Cresyl violet sections from this experiment are also being counted to determine if the
increased cell counts in the VMH and CORTEX are due to neurogenesis. Further
studies will be needed to determine if BDNF-IR cell changes are limited to a certain
population of neurons.
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Appendix A

Table 1
Dietary Components
______________________________________________________________________
Diet Components:
Western Diet for Rodents 5TJN
Laboratory Rodent Diet 5001
______________________________________________________________________
Protein, %

18.3

23.9

Fat, %

19.9

10.7

Fiber, %

7.0

5.1

Carbohydrate, %

49.5

48.7

Energy (kcal/g)^2

4.49

3.34

Protein

16.3

28.51

Fat

39.9

13.50

% of Diet From:

Carbohydrate
44.1
58.00
______________________________________________________________________

WD

CHOW

WD

WD-FR

48 hr
CHOW

WD

WD-FR

1 wk
CHOW

WD

WD-FR

3 wk
CHOW

+ 0.30

Weight

25.64 +
0.55

Intake

Body

Weight

Exposure

0.65

25.75 +

0.83

14.53 +

0.28

25.56 +

0.43

15.49 +

0.37

23.99 +

1.05

14.62 +

0.28

24.05 +

0.31

14.19 +

0.43

23.82 +

0.64

14.95 +

0.38

23.65 +

0.44

14.85 +

0.35

24.54 +

0.67

14.95 +

0.43

24.46 +

0.36

15.13 +

1.00

25.53 +

0.54

14.59 +

0.35

25.03 +

0.32

14.71 +

0.99

24.54 +

0.65

14.99 +

0.38

24.63 +

0.38

14.65 +

0.67

24.28 +

0.46

14.43 +

0.19

24.33 +

0.28

14.83 +

0.53

24.00 +

0.63

17.60 +

0.29

23.84 +

0.24

14.73 +

0.65

24.38 +

0.83

15.83 +

0.31

24.09 +

0.22

13.89 +

0.64

24.20 +

0.69

15.30 +

0.35

23.73 +

0.28

14.62 +

_________________________________________________________________________________________________________________________________

0.99

Food

Test Diet

14.53 +

25.093

Body

Day Prior to

0.11

Intake

Intake Period

15.52 +

Food

Stable Food

_________________________________________________________________________________________________________________________________

Time

6 hr

_________________________________________________________________________________________________________________________________

Food Intake and Body Weights During Stable Period and Prior to Test Diet Exposure
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Table 3
Experiment 1: BDNF-IR Cell Counts
____________________________________________________________________________
ARC
VMH
PVN
CORTEX
____________________________________________________________________________
FED

122.19 + 16.71

494.14 + 55.82

208.70 + 24.91

990.42 + 63.21

FAST
83.58 + 12.45
398.00 + 74.40
164.10 + 26.32
972.90 + 91.66
____________________________________________________________________________

165.58 + 23.44
141.63 + 13.09

WD-FR

104.00 + 12.14

CHOW
WD

81.33 + 20.13

WD-FR

101.27 + 19.19

CHOW
95.73 + 12.81

116.75 + 17.60

WD-FR

WD

108.71 + 14.70

130.19 + 12.87

CHOW
WD

156.77 + 19.20

WD

538.96 + 51.51

534 + 42.65

359.17 + 45.42

340.00 + 58.06

502.75 + 44.12

388.65 + 57.80

414.52 + 30.85

517.81 + 55.71

487.19 + 42.47

522.94 + 72.81

292.11 + 17.911

241.46 + 24.84

218.45 + 38.31

224.881 + 23.09

242.71 + 32.73

239.33 + 18.13

224.44 + 22.31

223.83 + 9.91

253.96 + 31.79

231.50 + 20.03

1431.37 + 71.16

1312.48 + 65.11

948.12 + 37.42

1011.36 + 57.56

1140.01 + 97.08

930.53 + 74.22

1088.60 + 58.60

1102.73 + 104.41

1359.33 + 64.15

1323.93 + 75.59

CHOW
146.13 + 11.32
507.65 + 41.79
282.00 + 11.64
1271.89 + 58.98
___________________________________________________________________________________________________________________

3wk

1wk

48hr

6hr

Time Point
Diet Type
ARC
VMH
PVN
CORTEX
___________________________________________________________________________________________________________________

___________________________________________________________________________________________________________________

Experiment 2: BDNF-IR Cell Counts
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Appendix B

Figure 1. a. Bilateral cresyl violet image of the VMH and ARC. b. Bilateral
fluorescent labeled VMH and ARC Third ventricle (3V). Scale bars 100 μm.
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Figure 2. a. Bilateral cresyl violet image of the PVN. b. Bilateral fluorescent labeled
PVN. c. Unilateral cresyl violet image of the ectorhinal CORTEX. d. Unilateral
fluorescent image of the ectorhinal CORTEX. Scale bars 100 μm.
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Figure 3. a. Fluorescent labeled VMH section. White square enlarged to the right
showing a sample of what cells are counted (above the threshold) and what cells are
not counted (below the threshold). b. Highlighted cells counted within the VMH.
Scale bars 100 μm.
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Figure 4. a. Experimental timeline. Experiment is divided into two pain parts: pre-test
diet exposure and test diet exposure. During pre-test diet exposure, animals stabilize
eating powdered chow and are briefly exposed to WD to prevent neophobia during test
diet exposure. During test diet exposure, animals receive test diet until time of
sacrifice. b. Experimental groups with number of animals per group.
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Experiment 1

Figure 5. Body weight and food intake for the 48-hour chow (FED) and fasted (FAST) animals are
shown above. There is no statistical difference between food intake (a.) and body weight (c.) before the
start of the fasting (days 1-5). Body weight and food intake between FED and FAST groups is
significantly different on days 6 and 7 (p < 0.01 ). (b. & d.). e. BDNF-IR cell counts show ARC BDNFIR cell decrease by 32% after a 48-hour fast (p < 0.05). No changes were seen in any other brain areas.
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Experiment 2

Figure 6. a. Food intake for the 6-hour diet duration group. Food intake was
decreased by 33% in the CHOW group compared to the WD group (p < 0.01). b.
There were no differences in body weight after the 6-hour diet duration. c. Six-hour
BDNF-IR Cell Counts. No differences were observed between the diet groups in any
of the brain areas.
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Figure 7. a. Food intake was increased in the WD 48-hour diet duration group
compared to WD-FR and CHOW groups (p < 0.05). b. There were no differences in
average body weight after 48-hours on the diet. c. Forty-eight hour BDNF-IR Cell
Counts showed no differences within any of the brain areas within this test diet
duration group. There were non-significant increasing trends within the VMH between
the WD and CHOW (p = 0.0671) and CORTEX (p = 0.0952).

57

Figure 8. a. Food intake for the one-week diet duration group averaged per day. Repeated measures
showed differences in food intake (p < 0.01). b. Food intake averaged over the entire week. WD was
different from WD-FR and CHOW (p < 0.01). c. Body weight for the one- week test diet duration group
averaged per day. Repeated measures showed significant differences in body weight (p < 0.01). d. Body
weight averaged over the entire week. WD was different from WD-FR and CHOW (p < 0.05). e.
BDNF-IR cell counts increased in the VMH by 29% (p < 0.05) and a 17% increase in the CORTEX (p <
0.05). No other differences were observed within this test diet duration group.
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Figure 9. a. Food intake averaged per day for the three-week group. Repeated measures showed
significant differences in food intake (p < 0.01). b. Food intake averaged over the entire three week
exposure period. Food intake was significantly less in the WD-FR group compared to WD and CHOW
groups (p < 0.05). c. Body weight averaged per day for the three-week group. d. Body weight averaged
across the entire three week exposure period. No significant differences were observed between the
three groups (p = 0.3340). e. No differences in BDNF-IR cell counts were observed between any of the
diet groups in any of the brain areas within this test diet duration group.

